论文信息 - Operational Challenges and Solutions with Implementation of an Adaptive Seamless Phase 2/3 Study

Operational Challenges and Solutions with Implementation of an Adaptive Seamless Phase 2/3 Study

A wide variety of operational issues were encountered with the planning and implementation of an adaptive, dose-finding, seamless phase 2/3 trial for a diabetes therapeutic. Compared with a conventional design, significant upfront planning was required, as well as earlier, more integrated cross-functional coordination. The existing infrastructure necessitated greater flexibility to meet the needs of the adaptive design. Rapid data acquisition, analysis, and reporting were essential to support the successful implementation of the adaptive algorithm. Drug supply for nine treatment arms had to be carefully managed across many sites worldwide. Details regarding these key operational challenges and others will be discussed along with resolutions taken to enable successful implementation of this adaptive, seamless trial.

[1] Susan A. Murphy,et al. Monographs on statistics and applied probability , 1990 .

[2] Michael Krams,et al. Implementing Adaptive Designs: Logistical and Operational Considerations , 2006 .

[3] Robert Tibshirani,et al. An Introduction to the Bootstrap , 1994 .

[4] Donald A. Berry,et al. Good Practices for Adaptive Clinical Trials in Pharmaceutical Product Development , 2009 .

[5] J. Chien,et al. An Adaptive, Dose-Finding, Seamless Phase 2/3 Study of a Long-Acting Glucagon-like Peptide-1 Analog (Dulaglutide): Trial Design and Baseline Characteristics , 2012, Journal of diabetes science and technology.

[6] L. Kux. OF HEALTH AND HUMAN SERVICES Food and Drug Administration , 2014 .

[7] Brenda Gaydos,et al. Application of Adaptive Design Methodology in Development of a Long-Acting Glucagon-like Peptide-1 Analog (Dulaglutide): Statistical Design and Simulations , 2012, Journal of diabetes science and technology.